The number of new COVID cases increased by 52 per cent during the past four-odd weeks, the WHO said, with over 850 000 new cases reported during the period.
The number of new deaths decreased by 8 per cent as compared to the previous 28-day period, with over 3,000 new fatalities reported, World Health Organization (WHO) said in its latest press release.
-
Neeru Dhanda Carried Homemade Churma To Asiad, Returned With Two Gold Medals -
Inside The Mind Of Archer Kumkum Mohod, Who Dared To Challenge South Korea -
"High Inflation Is Like Tax On Everyone": RBI Governor At NDTV World Summit -
AI Agents To Outnumber Humans Soon? What Futurist Mike Walsh Told NDTV -
This Delhi Boy Has 3 Michelin Stars. His Heart Still Goes To Rajindar Da Dhaba -
Ashwini Vaishnaw Explains Semiconductor Complexity: 'Everything On This Tiny Nail' -
Indian-Branded Mobile Phones By October 23, 2028, Says Ashwini Vaishnaw -
AI Law In India Soon? What Ashwini Vaishnaw Said At NDTV World Summit -
World's 1st AI Actor Tilly Norwood Was Asked If She Knew Hindi. A Conversation Followed -
Iran's Supreme Leader's Representative Says India Can Play 'Big Role' In Middle East Peace
As of December 17, over 772 million confirmed cases and nearly seven million deaths have been reported globally since the onset of COVID-19, the WHO noted.
Further, the WHO said over 118,000 new COVID-19 hospitalisations and over 1600 new intensive care unit (ICU) admissions have been recorded, with an overall increase of 23 per cent and 51 per cent, respectively, globally.
As of December 18, 2023, JN.1, a sub-lineage of BA.2.86 Omicron variant has been designated a separate variant of interest (VOI) apart from its parent lineage BA.2.86 due to its rapid increase in prevalence in recent weeks. Globally, EG.5 remains the most reported variant of interest.
Due to its rapidly increasing spread, WHO is classifying the variant JN.1 as a separate variant of interest (VOI) from the parent lineage BA.2.86. It was previously classified as VOI as part of BA.2.86 sublineages.
Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low. Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries.
The WHO had earlier said it was continuously monitoring the evidence and would update the JN.1 risk evaluation as needed.
Current vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of SARS-CoV-2, the virus that causes COVID-19, it noted.
COVID-19 is not the only respiratory disease circulating. Influenza, RSV, and common childhood pneumonia are also on the rise.
The WHO advises people to take measures to prevent infections and severe disease using all available tools. These include wearing a mask when in crowded, enclosed, or poorly ventilated areas, keeping a safe distance from others, practicing respiratory etiquette (covering coughs and sneezes), cleaning hands regularly, and getting tested if one has any symptoms or if you might have been exposed to someone with COVID-19 or influenza.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Track Latest News Live on NDTV.com and get news updates from India and around the world